Kiniksa Pharmaceuticals Ltd. (KNSA) to Offer $100M in Class A Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering
July 20, 2020 4:07 PM EDTHAMILTON, Bermuda, July 20, 2020 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa, we, and our) announced today that it is commencing a public offering of $100.0 million of Class A common shares. In addition, Kiniksa expects to grant the underwriters a 30-day option to purchase up to $15.0 million of additional Class A common shares. All of the Class A common shares are being offered by Kiniksa.
Kiniksa intends to use the net proceeds from the offering to advance the development of its product candidates, to advance commercialization activities and to fund... More
